<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saito R</submitter><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Science and Technology Agency</funding><funding>Japan Society for the Promotion of Science</funding><pagination>671</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8540909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(10)</volume><pubmed_abstract>Acute kidney injury (AKI) is defined as a rapid decline in kidney function. The associated syndromes may lead to increased morbidity and mortality, but its early detection remains difficult. Using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS), we analyzed the urinary metabolomic profile of patients admitted to the intensive care unit (ICU) after invasive surgery. Urine samples were collected at six time points: before surgery, at ICU admission and 6, 12, 24 and 48 h after. First, urine samples from 61 initial patients (non-AKI: 23, mild AKI: 24, severe AKI: 14) were measured, followed by the measurement of urine samples from 60 additional patients (non-AKI: 40, mild AKI: 20). Glycine and ethanolamine were decreased in patients with AKI compared with non-AKI patients at 6-24 h in the two groups. The linear statistical model constructed at each time point by machine learning achieved the best performance at 24 h (median AUC, area under the curve: 89%, cross-validated) for the 1st group. When cross-validated between the two groups, the AUC showed the best value of 70% at 12 h. These results identified metabolites and time points that show patterns specific to subjects who develop AKI, paving the way for the development of better biomarkers.</pubmed_abstract><journal>Metabolites</journal><pubmed_title>Urinary Metabolome Analyses of Patients with Acute Kidney Injury Using Capillary Electrophoresis-Mass Spectrometry.</pubmed_title><pmcid>PMC8540909</pmcid><funding_grant_id>OPERA JPMJOP1842</funding_grant_id><funding_grant_id>JP21ek0109544</funding_grant_id><funding_grant_id>1R01DK110541-01</funding_grant_id><funding_grant_id>KAKENHI JP20H05743</funding_grant_id><funding_grant_id>KAKENHI JP19K08689</funding_grant_id><funding_grant_id>KAKENHI JP18K08219</funding_grant_id><pubmed_authors>Saito R</pubmed_authors><pubmed_authors>Kato Y</pubmed_authors><pubmed_authors>Soga T</pubmed_authors><pubmed_authors>Tomita M</pubmed_authors><pubmed_authors>Ikeda S</pubmed_authors><pubmed_authors>Hirayama A</pubmed_authors><pubmed_authors>Kwan B</pubmed_authors><pubmed_authors>Maruyama S</pubmed_authors><pubmed_authors>Shinjo H</pubmed_authors><pubmed_authors>Natarajan L</pubmed_authors><pubmed_authors>Pu M</pubmed_authors><pubmed_authors>Kamei Y</pubmed_authors><pubmed_authors>Akiba A</pubmed_authors><pubmed_authors>Akiyama S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Urinary Metabolome Analyses of Patients with Acute Kidney Injury Using Capillary Electrophoresis-Mass Spectrometry.</name><description>Acute kidney injury (AKI) is defined as a rapid decline in kidney function. The associated syndromes may lead to increased morbidity and mortality, but its early detection remains difficult. Using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS), we analyzed the urinary metabolomic profile of patients admitted to the intensive care unit (ICU) after invasive surgery. Urine samples were collected at six time points: before surgery, at ICU admission and 6, 12, 24 and 48 h after. First, urine samples from 61 initial patients (non-AKI: 23, mild AKI: 24, severe AKI: 14) were measured, followed by the measurement of urine samples from 60 additional patients (non-AKI: 40, mild AKI: 20). Glycine and ethanolamine were decreased in patients with AKI compared with non-AKI patients at 6-24 h in the two groups. The linear statistical model constructed at each time point by machine learning achieved the best performance at 24 h (median AUC, area under the curve: 89%, cross-validated) for the 1st group. When cross-validated between the two groups, the AUC showed the best value of 70% at 12 h. These results identified metabolites and time points that show patterns specific to subjects who develop AKI, paving the way for the development of better biomarkers.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-18T17:27:46.519Z</modification><creation>2025-04-07T04:58:37.151Z</creation></dates><accession>S-EPMC8540909</accession><cross_references><pubmed>34677386</pubmed><doi>10.3390/metabo11100671</doi></cross_references></HashMap>